Valeant Pharmaceuticals, parent company of Bausch & Lomb, has initiated the search for a new chief executive following the resignation of J. Michael Pearson, who returned to the job after a two-month medical leave. He will remain on duty until the appointment of his successor. Meanwhile, Valeant announced the nomination ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.